Who is sponsoring NCT07214909?

NCT07214909 is sponsored by MetroHealth Medical Center.

What drugs are being tested in NCT07214909?

Interventions in NCT07214909: Ingesting coffee without creamer, Ingesting coffee with creamer.

What condition does NCT07214909 study?

NCT07214909 studies Gastric Emptying Time.

Is NCT07214909 still recruiting?

NCT07214909 is currently completed. Last updated 9 October 2025.

Last reviewed 2025-10-09 · How we verify

NCT07214909

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gastric POCUS Clear Liquids

Completed NA Last updated 9 October 2025

What this trial tests

NA trial testing Ingesting coffee without creamer in Gastric Emptying Time in 70 participants. Completed in 9 December 2024.

Timeline

18 January 2023

Primary endpoint
9 December 2024

9 December 2024

Quick facts

Lead sponsor	MetroHealth Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	70
Start date	18 January 2023
Primary completion	9 December 2024
Estimated completion	9 December 2024
Sites	1 location across United States

Drugs / interventions tested

Ingesting coffee without creamer
Ingesting coffee with creamer

Conditions studied

Gastric Emptying Time — all drugs for Gastric Emptying Time →

Sponsor

MetroHealth Medical Center

Who can join

Adults 18 to 65, any sex, with Gastric Emptying Time. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the gastric emptying time for clear liquids at different volumes in the adult population, for use in determining anesthesia guidelines.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other MetroHealth Medical Center trials

Trials by the same sponsor.

NCT06734026 — Multimodal, Enriched Environment for Rehabilitation in Chronic Traumatic Brain Injury · NA · recruiting
NCT06664892 — Ultrahypofractionated Whole Breast Radiation Following Chemotherapy · NA · not yet recruiting
NCT06788795 — Effectiveness of a Wearable Hydration Device · Phase 2 · not yet recruiting
NCT06836739 — At-Home Genital Nerve Stimulation for SCI Bowel · NA · recruiting
NCT06113965 — Neural Operant Conditioning · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07214909 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by MetroHealth Medical Center
Last refreshed: 9 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07214909.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing